Apr 2025 Prevalent Adulterants Found in the Illicit Drug Supply
Adulterants are unreported substances added to a product, often to reduce production costs, enhance the products effects, and may increase...
Clinical Update
Feb 2025 Novel Psychoactive Substances 2024: A Year in Review
New or Novel Psychoactive Substances (NPS) are a diverse group of synthetic substances created to mimic the effects of prescription...
Nov 2024 Ketamine: Considerations in Clinical Practice
Ketamine is a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist. It is FDA approved for the induction and maintenance of anesthesia.1 When used...
Aug 2024 Telemedicine Improvements After Epidemics Collide
Telemedicine, or telehealth, utilizes telecommunication technologies through audio or audio/visual, real-time, two-way communication to provide clinical services to patients outside...
Jul 2024 Poppy Seeds and Opiate Testing
Q: Is it possible for individuals to test positive for opiates following poppy seed consumption? A: Yes. relatively low levels of morphine...
Jun 2024 New Nitazene Data – Ongoing Evaluation of an Emerging Threat
Gabapentin (Neurontin, Gralise, Horizant) was first approved by the US Food and Drug Administration (FDA) in 1993 for the treatment...
